Formulation Development and Characterization of Diltiazem Pulsin Cap for Pulsatile Drug Delivery

Alisha Ishrath, Venkataratnam Devadas, M. M. Ahmed
{"title":"Formulation Development and Characterization of Diltiazem Pulsin Cap for Pulsatile Drug Delivery","authors":"Alisha Ishrath, Venkataratnam Devadas, M. M. Ahmed","doi":"10.46624/ajptr.2019.v9.i5.009","DOIUrl":null,"url":null,"abstract":"Please cite this article as: Ishrath A et al., Formulation Development and Characterization of Diltiazem Pulsin Cap for Pulsatile Drug Delivery . American Journal of PharmTech Research 2019. Formulation Development and Characterization of Diltiazem Pulsin Cap for Pulsatile Drug Delivery Alisha Ishrath, Venkataratnam Devadas, Mohammed Mazher Ahmed 1.Department of Pharmaceutics, MAK College of Pharmacy, Hyderabad, Telangana, India 2.Department of Pharmaceutics, Luqman College of Pharmacy, Gulbarga, Karnataka, India ABSTRACT The aim of this work is to develop modified drug release by using Pulsin Cap technique with Diltiazem as model drug. From the above experimental results, it can be concluded that, Formulated granules gave satisfactory results for various micromeritic properties, dissolution and drug content. Formulated Pulsin Cap gave satisfactory results for various physicochemical parameters like weight variation. HPMC, Ethyl cellulose has predominant effect on the lag time, while also shows significant effect on drug release. Diltiazem Pulsin Cap shows a delayed release pattern. Among all the Diltiazem granules formulations F5 was selected based on drug release within a given period of time. In-vitro release rate studies showed that the PF5 was optimized based on less amount of drug release during lag time. Formulations PF5 found to be stable at 40 C and 75% RH for a period of 3 months. FT-IR studies revealed that there was no interaction between Diltiazem and the polymers.","PeriodicalId":7701,"journal":{"name":"American Journal of PharmTech Research","volume":"26 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of PharmTech Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46624/ajptr.2019.v9.i5.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Please cite this article as: Ishrath A et al., Formulation Development and Characterization of Diltiazem Pulsin Cap for Pulsatile Drug Delivery . American Journal of PharmTech Research 2019. Formulation Development and Characterization of Diltiazem Pulsin Cap for Pulsatile Drug Delivery Alisha Ishrath, Venkataratnam Devadas, Mohammed Mazher Ahmed 1.Department of Pharmaceutics, MAK College of Pharmacy, Hyderabad, Telangana, India 2.Department of Pharmaceutics, Luqman College of Pharmacy, Gulbarga, Karnataka, India ABSTRACT The aim of this work is to develop modified drug release by using Pulsin Cap technique with Diltiazem as model drug. From the above experimental results, it can be concluded that, Formulated granules gave satisfactory results for various micromeritic properties, dissolution and drug content. Formulated Pulsin Cap gave satisfactory results for various physicochemical parameters like weight variation. HPMC, Ethyl cellulose has predominant effect on the lag time, while also shows significant effect on drug release. Diltiazem Pulsin Cap shows a delayed release pattern. Among all the Diltiazem granules formulations F5 was selected based on drug release within a given period of time. In-vitro release rate studies showed that the PF5 was optimized based on less amount of drug release during lag time. Formulations PF5 found to be stable at 40 C and 75% RH for a period of 3 months. FT-IR studies revealed that there was no interaction between Diltiazem and the polymers.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脉动给药用地尔硫卓脉冲帽的配方研制与表征
请引用这篇文章:Ishrath A等人,用于脉动给药的地尔硫卓脉冲帽的配方开发和表征。美国医药技术研究杂志2019。脉动给药用地尔硫卓脉冲帽的处方开发与表征印度特伦甘纳邦海得拉巴MAK药学院药剂学系摘要本研究以地尔硫卓为模型药物,采用Pulsin Cap技术研究药物的修饰释放。从上述实验结果可以看出,所配制的颗粒剂在各种显微性质、溶出度和药物含量方面都取得了令人满意的效果。所配制的Pulsin Cap对重量变化等理化参数均有满意的效果。HPMC、乙基纤维素对缓释时间有显著影响,对缓释时间也有显著影响。地尔硫卓脉欣帽呈延迟释放模式。在所有的地尔硫卓颗粒制剂中,F5是根据给定时间内的药物释放来选择的。体外释药率研究表明,PF5以较低的滞后期释药量为优化目标。配方PF5在40℃和75% RH下稳定3个月。红外光谱研究表明,地尔硫卓与聚合物之间没有相互作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Prospective Study to Assess the Efficacy and Risk Associated With the Use of Bronchodilators in Pediatric Patients with Bronchiolitis – A Pilot Study Formulation and Development Matrix Tablets Of Methimazole Development and Evaluation of Indomethacin Parenteral Delivery of Microspheres for the Treatment of Gout Study the effect of Dipeptidyl Peptidase 4 Inhibitors as an Antidiabetic in Type 2 Diabetes Mellitus (T2DM) Particle Engineering and Spray Drying Process designing for Solubility Enhancement of Lopinavir
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1